Back to search

Article

Profiling potential targets of anlotinib in human synovial sarcoma patients and immunocompetent mouse models

2025-12-02

Abstract excerpt

<h4>ABSTRACT</h4> Synovial sarcoma (SS) is an aggressive translocation-driven malignancy characterized by its driving SS18::SSX fusion oncogene. This rare but deadly cancer presents limited treatment options despite an emerging understanding of its dependency on receptor tyrosine kinases (RTKs). Anlotinib is a multi-target tyrosine kinase inhibitor (TKI) that was recently approved in China for treatment of soft t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3a66ea03-ff1e-5176-80d3-687cfd166605
DOI
10.64898/2025.11.30.25341318
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Profiling potential targets of anlotinib in human synovial sarcoma patients and immunocompetent mouse modelsDOI 10.64898/2025.11.30.25341318
Opposing immune and genetic forces shape oncogenic programs in synovial sarcomaSemantic proximity
Molecular Profiling Defines Three Subtypes of Synovial SarcomaSemantic proximity
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational ResearchSemantic proximity
SUMO2 Inhibition Reverses Aberrant Epigenetic Rewiring Driven by Synovial Sarcoma Fusion Oncoproteins and Impairs SarcomagenesisSemantic proximity
Cell-of-origin epigenome underlies SS18::SSX-mediated transformationSemantic proximity
Molecular and epigenetic oncogenesis in synovial sarcoma: implications for cancer biology, diagnosis and treatmentSemantic proximity
Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in TherapySemantic proximity
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial SarcomaSemantic proximity
Integrative multi-omics analysis reveals molecular subtypes and tumor evolution of synovial sarcomaSemantic proximity
Biology and Therapy of Dominant Fusion Oncoproteins Involving Transcription Factor and Chromatin Regulators in SarcomasSemantic proximity
The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.Semantic proximity
ATR Is a Therapeutic Target in Synovial SarcomaSemantic proximity
Select a neighboring publication to make it the new centre.